Company: GVH
Filing Date: 2025-06-27
Form Type: 424B4
Source: 0001213900-25-058674
Chunk: 64

Company: Globavend Holdings Ltd
Filing Date: 2025-06-27
Form: 424B4
Chunk 64
---
 materially adversely affect our liquidity and investors’ investment in our securities.

If the holders of the Series B Warrants elect to exercise such warrants using the zero exercise price option, we may not receive any additional funds and our Shareholders will suffer substantial dilution.

The Series B Warrants
contain a zero exercise price provision which provides the holders the right, at their option, to receive a number of Ordinary Shares
equal to the product of (a) the number of shares that would be issuable upon exercise of the Series B Warrant in accordance
with the terms of such warrant if such exercise were by means of a cash exercise rather than a cashless exercise and (b) the quotient
obtained by dividing (i) the exercise price minus the Low Price by (ii) 50% of the Low Price. This “zero exercise price”
option is only available at a time when the Low Price is lower than the then applicable Exercise Price. At no time can the Low Price be
lower than the Floor Price. As a result of this feature, we do not expect to receive any cash proceeds from the exercise of the Series B
Warrants in these circumstances because it is highly unlikely that a Series B Warrant holder will elect to pay an exercise price
in cash to receive one Ordinary Share at a time when they could elect the zero exercise price option to receive more Ordinary Shares than
they would receive if they did pay an exercise price.

Based on the Floor Price of $0.1395, an exercising holder of a Series B
Warrant is entitled to receive up to 15 Ordinary Shares for each Series B Warrant they exercise if the market price for the Ordinary
Shares drops to the Floor Price, or 322,113,130 Ordinary Shares in the aggregate. If holders elect the zero exercise price option, on
this basis, such exercise will result in substantial dilution to stockholders.

The Warrants have beneficial ownership limitations.

An investment in the Units involves
a significant risk due to the 4.99% (or 9.99% if the investor so elects) beneficial ownership limitation that the Warrants are subject
to. The terms of the Warrants prohibit any single holder from exercising the Warrants if such exercise would result in the holder beneficially
owning more than 4.99% (or 9.99% if the investor so elects) of our outstanding Ordinary Shares immediately after the exercise, as elected
by the holder at the time of issuance of the warrants